BUNGE GLOBAL SA (BG) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Operating income ÷ reported interest expense. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 17.94B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | 705.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $17.94B | (m) | (m) | $705.00M | (m) | (m) | (m) | Reported |
| 2025-12-31 | $28.00M | $16.94B | (m) | (m) | $628.00M | 0.17% | (m) | (m) | Reported |
| 2025-09-30 | (m) | $16.06B | (m) | (m) | $525.00M | (m) | (m) | (m) | Reported |
| 2025-06-30 | (m) | $15.56B | (m) | (m) | $450.00M | (m) | (m) | (m) | Reported |
| 2025-03-31 | (m) | $15.27B | (m) | (m) | $467.00M | (m) | (m) | (m) | Reported |
| 2024-12-31 | $30.00M | $15.55B | (m) | (m) | $471.00M | 0.19% | (m) | (m) | Reported |
| 2024-09-30 | (m) | $15.92B | (m) | (m) | $500.00M | (m) | (m) | (m) | Reported |
| 2024-06-30 | (m) | $16.40B | (m) | (m) | $506.00M | (m) | (m) | (m) | Reported |
| 2024-03-31 | (m) | $17.05B | (m) | (m) | $512.00M | (m) | (m) | (m) | Reported |
| 2023-12-31 | $35.00M | $17.83B | (m) | (m) | $516.00M | 0.20% | (m) | (m) | Reported |
| 2023-09-30 | (m) | $30.12B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $42.53B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $9.92B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $33.00M | $21.07B | (m) | (m) | $403.00M | 0.16% | (m) | (m) | Reported |
| 2021-12-31 | $33.00M | $16.81B | (m) | (m) | $243.00M | 0.20% | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DARLING INGREDIENTS INC. (DAR) | United States | $9.740B | 15.03 |
| Archer-Daniels-Midland Co (ADM) | United States | $39.458B | 20.81 |